effects of stopping glp-1 medication Taking GLP‑1 Without Diabetes in 2026: What Real People Notice After 3, 6 and 12 Months In recent years, GLP-1 medications

Promotes Lean Mass and Body Composition: Supports healthier body composition by encouraging fat-loss goals alongside lean mass support

Synthetic exendin-4 became exenatide, marketed as Byetta, and in 2005, it became the first GLP-1 receptor agonist approved by the FDA for the treatment of type 2 diabetes

Key takeaways Structured weight management programs (SWMPs) must strategically align with GLP-1 treatments while distancing themselves from outdated diet culture perceptions

Caroline Apovian, MD , co-director at the Center for Weight Management and Wellness at Brigham and Women's Hospital, agrees that hormones may be at play

This may mean reducing your caloric intake again by a small amount